Equities

Haleon PLC

HLN:LSE

Haleon PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)398.10
  • Today's Change-1.20 / -0.30%
  • Shares traded8.15m
  • 1 Year change5.32%
  • Beta0.3806
Data delayed at least 20 minutes, as of Feb 06 2026 16:36 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.

  • Revenue in GBP (TTM)--
  • Net income in GBP--
  • Incorporated2021
  • Employees24.00k
  • Location
    Haleon PLCBuilding 5, First Floor, The HeightsWEYBRIDGE KT13 0NYUnited KingdomGBR
  • Phone+44 19 3282 2000
  • Websitehttps://www.haleon.com/
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Teva Pharmaceutical Industries Ltd12.67bn1.03bn29.17bn31.17k29.17bn31.17k
Alnylam Pharmaceuticals, Inc.2.36bn32.00m31.85bn2.23k31.85bn2.23k
Sun Pharmaceutical Industries Ltd4.61bn850.80m32.98bn43.00k32.98bn43.00k
Haleon PLC-100.00bn-100.00bn35.46bn24.00k35.46bn24.00k
Jiangsu Hengrui Pharmaceuticals Co Ltd3.28bn790.58m38.70bn20.24k38.70bn20.24k
Bayer AG39.81bn-171.87m39.06bn88.50k39.06bn88.50k
Takeda Pharmaceutical Co Ltd20.86bn527.63m41.01bn47.46k41.01bn47.46k
Zoetis Inc6.90bn1.95bn41.25bn13.80k41.25bn13.80k
UCB SA5.94bn1.16bn44.24bn9.38k44.24bn9.38k
CSL Ltd11.58bn2.23bn45.13bn32.07k45.13bn32.07k
Data as of Feb 06 2026. Currency figures normalised to Haleon PLC's reporting currency: UK Pound GBX

Institutional shareholders

21.20%Per cent of shares held by top holders
HolderShares% Held
Wellington Management Co. LLPas of 23 Sep 2025359.60m4.04%
Dodge & Coxas of 30 Sep 2024233.28m2.62%
The Vanguard Group, Inc.as of 01 Jan 2026223.09m2.51%
BlackRock Fund Advisorsas of 06 Mar 2025196.79m2.21%
BlackRock Investment Management (UK) Ltd.as of 01 Jan 2026181.50m2.04%
MFS International (UK) Ltd.as of 01 Jan 2026172.01m1.93%
Harding Loevner LPas of 01 Jan 2026132.71m1.49%
Franklin Mutual Advisers LLCas of 01 Jan 2026131.98m1.48%
Norges Bank Investment Managementas of 01 Jan 2026129.69m1.46%
First Eagle Investment Management LLCas of 01 Jan 2026127.54m1.43%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.